9. HORMONES Flashcards

SMALL ANIMALS

1
Q

treatment of canine hypothyroidism

A

-LEVOTHYROXINE
synthetic form of thyroxine T4: life long T4 supplement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

levothyroxine: goal

A

no clinical signs of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

levothyroxine monitoring

A

clinical response + peak TT4 concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

levothyroxine improvement

A

can take weeks to months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

levothyroxine overdose

A

dogs are resistant to thyrotoxic effects of excessive T4 supplement
-up to 20x standard dosage
-clinical thyrotoxicosis over 90 nmol/l: panting, weight loss, hyperactivity, tachycardia, hyperthermia
>most signs resolve within few days of withdrawing therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

levothyroxine gradual introduction

A

with concurrent illness : cardiac, hypoadrenocorticism, DM
>25-50% of starting dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

treatment of feline hyperthyroidism

A

anti-thyroid drugs: METHIMAZOLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

methimazole if too much

A

T4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

methimazole anti-thyroid drug decrease production of

A

thyroid hormone, decrease circulating concentrations of thyroid hormone, reverse thyrotoxicosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

methimazole dose must be

A

titrated to individual needs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

methimazole …. within 2-3 weeks

A

euthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

methimazole doses adjusted to achieve

A

basal serumm tT4 concentration that is at or below middle of reference range for tT4
>trandermal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

methimazole adverse effects within… and life threatining adverse effects

A

first 3 month
> life–threatining adverse effects: agranulocytosis, thrombocytopenia, severe hepatopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

methimazole common and mild adverse effects

A

-GI signs: nausea, vomiting, lethargy, diarrhea
-leukopenia
-eosinophilia
-lymphocytosis>usually resolve despite continuing treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

methimazole … therapy

A

life long

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

….tends to advance despite treatment with anti-thyroid drugs, thus commonly necessitates increases in drug dosage over time > in order to maintain euthyroidism

A

feline hyperthyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

…. regulates glucose metabolism

A

insulin

18
Q

increases glucose uptake in peripheral tissues, increases glucose storage in liver, inhibits gluconeogenesis

A

insulin

19
Q

insulin, treatment of

A

diabetes mellitus

20
Q

insulin goal

A

control blood glucose below renal threshold as much of 24h period as possible > improve clinical signs > avoid clinically significant hypoglycemia

21
Q

feline insulin

A

glargine insulin: long acting

22
Q

canine insulin

A

porcine insulin zinc: intermediate acting

23
Q

insulin dosage based on

A

patients estimated ideal body weight

24
Q

insulin dosage should not be

A

increased more than q1-2w

25
Q

insulin pharmacokinetics

A

vary depending on: insulin type, product formulation and individual patient’s response

26
Q

insulin … window on each side of dosing interval

A

12 +/- 2h

27
Q

…inactivated insulin

A

freezing/heating

28
Q

insulin dosing

A

pens

29
Q

treatment for canine pituitary dependent hyperadrenocorticism=CUSHING SYNDROME

A

trilostane

30
Q

trilostane inhibit

A

synthesis of adrenocortical hormones cortisol and aldosterone

31
Q

cushing syndrome, trilostane, goal

A

control of cortisol secretion

32
Q

trilostane administer

A

with food q12h

33
Q

trilostane monitoring

A

-frequent monitoring : clinical signs > ACTHST

34
Q

trilostane adverse effects

A

-well tolerated
-lethargy
-mild electrolyte abnormalities
-GI signs: vomiting, diarrhea, inappetence

35
Q

treatment of canine hypoadrenocorticism: ADDISON’S DISEASE

A

glucocorticoids

36
Q

canine hypoadrenocorticism: ADDISON’S DISEASE has … deficiency

A

glucocorticoid (+mineralcorticoid)

37
Q

chronic treatment of glucocorticoids

A

predisolone PO
-life-long supplementation

38
Q

treatment of typical hypoadrenocorticism in addition to glucocorticoid

A

mineralcorticoids
:deoxycorticosterone pilavate (DOCP)/fludrocortisone
>electrolyte monitorin; Na ja K

39
Q

fludrocortisone

A

mineralcorticoids
-dose adjusted by assessing serum Na and K conc > increase until Na:K is >28

40
Q
A